Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, SA, Australia.
Perit Dial Int. 2011 Nov-Dec;31(6):663-71. doi: 10.3747/pdi.2010.00209. Epub 2011 May 31.
The number of elderly patients with end-stage kidney disease (ESKD) is increasing worldwide, but the proportion of elderly patients commencing peritoneal dialysis (PD) is falling. The reluctance of elderly ESKD patients to consider PD may be related to a perception that PD is associated with greater rates of complications. In the present study, we compared outcomes between younger and older PD patients.
Using Australia and New Zealand Dialysis Registry data, all adult ESKD patients commencing PD between 1991 and 2007 were categorized into under 50, 50 - 64.9, and 65 years of age or older groups. Time to first peritonitis, death-censored technique failure, and peritonitis-associated and all-cause mortality were evaluated by multivariate Cox proportional hazards model analysis.
Of the 12 932 PD patients included in the study, 3370 (26%) were under 50 years of age, 4386 (34%) were 50 - 64.9 years of age, and 5176 (40%) were 65 years of age or older. Compared with younger patients (<50 years), elderly patients (≥ 65 years) had a similar peritonitis-free survival and a lower risk of death-censored technique failure [hazard ratio (HR): 0.85; 95% confidence interval (CI): 0.79 to 0.93], but they had higher peritonitis-related (HR: 2.31; 95% CI: 1.68 to 3.18) and all-cause mortality (HR: 2.90; 95% CI: 2.60 to 3.23).
Not unexpectedly, elderly patients have higher peritonitis-related and all-cause mortality, which is likely a consequence of a greater prevalence of comorbid disease. However, compared with younger patients, elderly patients have superior technique survival and similar peritonitis-free survival, suggesting that PD is a viable renal replacement therapy in this group of patients.
全球范围内,终末期肾病(ESKD)老年患者的数量不断增加,但开始接受腹膜透析(PD)的老年患者比例却在下降。老年 ESKD 患者不愿意考虑 PD 的原因可能是他们认为 PD 与更高的并发症发生率有关。在本研究中,我们比较了年轻和老年 PD 患者的结局。
利用澳大利亚和新西兰透析登记处的数据,将 1991 年至 2007 年间开始 PD 的所有成年 ESKD 患者分为<50 岁、50-64.9 岁和 65 岁及以上年龄组。通过多变量 Cox 比例风险模型分析评估首次腹膜炎、死亡相关技术失败、腹膜炎相关和全因死亡率的时间。
在纳入研究的 12932 名 PD 患者中,3370 名(26%)年龄<50 岁,4386 名(34%)年龄 50-64.9 岁,5176 名(40%)年龄 65 岁及以上。与年轻患者(<50 岁)相比,老年患者(≥65 岁)的腹膜炎无复发生存率相似,死亡相关技术失败的风险较低[风险比(HR):0.85;95%置信区间(CI):0.79 至 0.93],但他们的腹膜炎相关(HR:2.31;95%CI:1.68 至 3.18)和全因死亡率(HR:2.90;95%CI:2.60 至 3.23)更高。
不出所料,老年患者的腹膜炎相关和全因死亡率更高,这可能是合并症患病率较高的结果。然而,与年轻患者相比,老年患者的技术生存率更高,腹膜炎无复发生存率相似,这表明 PD 是该组患者可行的肾脏替代治疗方法。